Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00435318
Status:
WITHDRAWN
Last Update Posted:
2015-12-08
First Post:
2007-02-12
Brief Title:
Lateral Epicondylitis Iontophoresis Randomized Control Trial LERCT
Sponsor:
Vanderbilt University
Organization:
Vanderbilt University
Study Overview
Official Title:
Lateral Epicondylitis Iontophoresis Randomized Control Trial LERCT
Status:
WITHDRAWN
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study approval deferred by the IRB
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The intent of this double-blinded study is to investigate the short 2 months and long-term over 2 months therapeutic capabilities of Iontophoresis
Detailed Description:
The intent of this double-blinded study is to investigate the short 2 months and long-term over 2 months therapeutic capabilities of Iontophoresis We anticipate that patients treated with Iontophoresis will have improved scores on the VAS and DASH assessments and will recover more quickly than those patients receiving the Sham treatment A Sham treatment is a method used in medical trials to help researchers determine the effectiveness of a drugtreatment which in this case will be Iontophoretic Administration using Dexamethasone Placebos are inactive substances Saline used in this study to compare results with an active substance Dexamethasone Furthermore it is the hope of this research team that through careful analysis and comparison of these two treatment arms a clear conclusion is met regarding the efficacy of Iontophoresis as a powerful treatment paradigm for patients suffering from this disorder
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None